Filter posts

Different Perspectives for AHIP to Consider During Today’s Discussion on Drug Costs

This week, America’s Health Insurance Plans, or AHIP, is hosting its annual health policy conference. …

Why a New Study on Drug Costs Misses the Mark

BIO President and CEO Jim Greenwood recently described 2017 as a “transformative year in medicine.” …

ICYMI: Major Canadian Online Pharmacy Caught Red Handed Selling Fake Drugs to the U.S.

The Wall Street Journal reports that companies controlled by the online pharmacy Canada Drugs have …

BIO’s Tom DiLenge Testifies on Biotechnology Innovation Ecosystem before House E&C #SubHealth

At a hearing today held by the House Energy and Commerce Subcommittee on Health on …

Five Questions for the Senate Hearing on Prescription Drugs

On Tuesday, the Senate Committee on Health, Education, Labor, and Pensions will hold its third …

NYTimes Reports Insurers are Struggling, Their Own Data Says Otherwise

The New York Times’ Reed Abelson yesterday reported on the plight of insurers who are …